Anti-TIF1γ antibody-positive dermatomyositis in a 15-year-old boy with Epstein–Barr virus-related nasopharyngeal cancer receiving nivolumab-Reference-Cited by-同舟云学术

Anti-TIF1γ antibody-positive dermatomyositis in a 15-year-old boy with Epstein–Barr virus-related nasopharyngeal cancer receiving nivolumab

Published:2020-12-25 Issue:6 Volume:60 Page:e197-e199
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Asano Ryoko¹,Shinoda Koichiro¹^ORCID,Tsuda Reina¹,Hounoki Hiroyuki¹,Kawataka Masatoshi¹,Makino Teruhiko²^ORCID,Imura Johji³,Hamaguchi Yasuhito⁴,Tobe Kazuyuki¹

Affiliation:

1. First Department of Internal Medicine, Toyama, Japan

2. Department of Dermatology, Toyama, Japan

3. Department of Diagnostic Pathology, University of Toyama, Toyama, Japan

4. Department of Dermatology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/60/6/e197/38695054/keaa832.pdf

Reference8 articles.

1. The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody-positive dermatomyositis;Oldroyd;Rheumatology,2019

2. Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins;Fujimoto;Arthritis Rheum,2012

3. Anti-TIF1-gamma-positive young adult dermatomyositis with germ cell tumour;Taki;Eur J Dermatol,2016

4. Inflammatory myopathy associated with PD-1 inhibitors;Seki;J Autoimmun,2019

5. Anti-transcriptional intermediary factor 1-gamma antibody-positive dermatomyositis induced by nivolumab for lung adenocarcinoma: a case report;Osaki;Invest New Drugs,2020

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating the disparities among drug categories in drug-induced dermatomyositis: A systematic review;Seminars in Arthritis and Rheumatism;2024-08

2. Immune Checkpoint Inhibitor-induced Myositis;Rheumatic Disease Clinics of North America;2024-05

3. Causes and Clinical Presentation of Drug-Induced Dermatomyositis;JAMA Dermatology;2024-02-01

4. Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature;Autoimmunity Reviews;2023-08

5. Anti-TIF1γ antibody-positive dermatomyositis associated with nivolumab administration in a patient with advanced oesophageal squamous cell carcinoma: A case report and literature review;Modern Rheumatology Case Reports;2023-01-30